Simon Amy's Form 4 filing
Beam Therapeutics Inc. (BEAM) · filed Apr 3, 2025
- Accession no.
- 0000950170-25-050852
- Filed
- Apr 3, 2025
- Trade date
- Apr 1-2, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $547.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Simon AmyCIK 0001963879 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | Common Stock | SSaleDisposed | −9,566 | $18.35 | −$175,536.1 | 86,739 | Direct | |
| Apr 2, 2025 | Common Stock | SSaleDisposed | −20,997 | $17.73 | −$372,276.81 | 65,742 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.